Measuring the Real Impact of Europe’s Cancer Policies on Patients – European Cancer Organisation
European Cancer Organisation/LinkedIn

Measuring the Real Impact of Europe’s Cancer Policies on Patients – European Cancer Organisation

European Cancer Organisation shared on LinkedIn:

“How can we know whether Europe’s cancer policies are genuinely improving patients’ lives?

Despite growing political attention, access to survivorship and support services remains uneven and fragmented across Europe.

At the European Cancer Summit, Marta Temido MEP joined the European Cancer Organisation’s Survivorship and Quality of Life Network Co-Chairs, Luzia Travado and Anne Letsch, alongside other policymakers, researchers and patient advocates, to examine persistent inequalities in cancer care, particularly gaps in implementation, access and outcomes.

The discussion also featured Jan Geissler, CEO of Patvocates; Cinzia Brunelli, Senior Researcher at Istituto Nazionale Tumori, Milan, and Coordinator of the EUonQoL project; and Gina Russo, Vice President of Global Public Affairs at Intuitive Surgical.

An early prototype of a potential European Survivorship and Quality of Life Self-Assessment Tool was also presented.

Key takeaways from the discussion:

  • Where you live still decides the quality of your care and your life during and after cancer. Survivorship should be treated as a matter of equity and rights, not left to geography or to a patient’s ability to navigate the system.
  • What gets measured gets done. Quality of life must be recognised as a core cancer outcome, measured systematically through patient-reported outcome and experience measures (PROMs and PREMs), and used to inform policy and investment decisions.
  • We need to move from commitments to accountability. Clear, measurable criteria can show where countries are falling short, and the EU and national governments can use them as a shared reference to turn monitoring into concrete policy action.

MEP Temido highlighted: ‘The success of our fight against cancer should not be measured by survival rates alone, but should also reflect the quality of life of patients, survivors and their families’

Explore ECO’s work on survivorship and quality of life and get involved in the Network!”

Measuring the Real Impact of Europe’s Cancer Policies on Patients - European Cancer Organisation

You can also read: European Cancer Summit 2026: Investing for High Returns: Making the Economic Case for Cancer Control in Europe.

Measuring the Real Impact of Europe’s Cancer Policies on Patients - European Cancer Organisation